Since exercise effects are extremely multifaceted and NAFLD may benefit from “secondary” effects such as weight loss or improved insulin sensitivity, it is difficult to narrow down to specific pathways regarding the molecular mechanisms of exercise benefits in NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.